Published in Biochem Biophys Res Commun on June 16, 1981
Alterations in the heart sarcolemmal Ca2+ transport activity by some beta-adrenergic antagonists. Basic Res Cardiol (1985) 0.75
Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol (1982) 1.87
Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol (1983) 1.36
Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res (1998) 1.29
Calcium movements in relation to heart function. Basic Res Cardiol (1982) 1.26
Structural and functional changes associated with failure and recovery of hearts after perfusion with Ca2+-free medium. J Mol Cell Cardiol (1975) 1.22
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol (1983) 1.15
Myocardial cation contents during induction of calcium paradox. Am J Physiol (1979) 1.11
Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol (1999) 1.07
Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects. Physiol Rev (1999) 1.07
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes (2001) 1.04
Calmidazolium and compound 48/80 inhibit calmodulin-dependent protein phosphorylation and ATP-dependent Ca2+ uptake but not Ca2+-ATPase activity in skeletal muscle sarcoplasmic reticulum. J Biol Chem (1984) 1.04
Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res (1986) 1.02
Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol (1987) 1.02
Depression of heart sarcolemmal Ca2+-pump activity by oxygen free radicals. Am J Physiol (1989) 0.99
Sarcoplasmic reticulum Ca(2+)/Calmodulin-dependent protein kinase is altered in heart failure. Circ Res (2000) 0.98
Modification of a discontinuous and highly porous sodium dodecyl sulfate-polyacrylamide gel system for minigel electrophoresis. Anal Biochem (1990) 0.98
Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol (1985) 0.98
Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci U S A (1983) 0.98
Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J Pharmacol Exp Ther (1999) 0.98
Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol (1983) 0.98
The transphosphatidylation activity of phospholipase D. Mol Cell Biochem (1996) 0.98
Alterations in cardiac membrane Ca2+ transport during oxidative stress. Mol Cell Biochem (1990) 0.97
Correlation between changes in the endogenous energy stores and myocardial function due to hypoxia in the isolated perfused rat heart. Can J Physiol Pharmacol (1972) 0.97
Alternative splicing in intracellular loop connecting domains II and III of the alpha 1 subunit of Cav1.2 Ca2+ channels predicts two-domain polypeptides with unique C-terminal tails. J Biol Chem (2001) 0.97
Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency. Ann Thorac Surg (2001) 0.96
Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure. Mol Cell Biochem (2000) 0.96
Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol. J Mol Cell Cardiol (1975) 0.95
Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J (1992) 0.94
Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J (1981) 0.94
Cardiac myofibrillar ATPase activity in diabetic rats. J Mol Cell Cardiol (1981) 0.94
Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart. Am J Physiol (1983) 0.93
Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem (2000) 0.93
Identification of low molecular weight GTP-binding proteins and their sites of interaction in subcellular fractions from skeletal muscle. J Biol Chem (1991) 0.93
Excitation-contraction coupling in heart. 3. Evidence against the involvement of adenosine cyclic 3',5'-monophosphate in calcium transport by sarcotubular vesicles of canine myocardium. Mol Pharmacol (1970) 0.93
Role of extracellular matrix proteins in heart function. Mol Cell Biochem (1993) 0.93
Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem (1997) 0.93
Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Physiol (1987) 0.93
Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J (2003) 0.92
Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion. Am J Cardiol (1975) 0.92
Subcellular distribution of dystrophin in isolated adult and neonatal cardiac myocytes. Am J Physiol (1994) 0.92
Direct effects of adriamycin on the rat heart sarcolemma. Res Commun Chem Pathol Pharmacol (1984) 0.92
Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes (1988) 0.92
Troponin I phosphorylation in heart homogenate from diabetic rat. Biochim Biophys Acta (1996) 0.91
Excitation-contraction coupling in heart. VI. Demonstration of calcium activated ATPase in the dog heart sarcolemma. Life Sci I (1971) 0.91
Molecular cloning, expression, and chromosomal assignment of sarcolemmal-associated proteins. A family of acidic amphipathic alpha-helical proteins associated with the membrane. J Biol Chem (1997) 0.91
Myocardial cell damage during experimental infective endocarditis. Lab Invest (1975) 0.91
Regulatory role of membrane systems in heart function. Can J Physiol Pharmacol (1977) 0.91
Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol (1992) 0.90
Alternative splicing, expression, and genomic structure of the 3' region of the gene encoding the sarcolemmal-associated proteins (SLAPs) defines a novel class of coiled-coil tail-anchored membrane proteins. J Biol Chem (2000) 0.90
Oscillations of intramuscular pH in perfused rat heart. Can J Physiol Pharmacol (1973) 0.90
Alterations in protein kinase A and protein kinase C levels in heart failure due to genetic cardiomyopathy. Can J Cardiol (1999) 0.90
Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow. J Cardiovasc Pharmacol (1994) 0.89
Subcellular calcium transport in failing hearts due to calcium deficiency and overload. Am J Physiol (1976) 0.89
Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J Pharmacol Exp Ther (1998) 0.89
Phospholipase D activity in subcellular membranes of rat ventricular myocardium. Biochim Biophys Acta (1991) 0.89
Sarcolemmal Na(+)-K(+)-ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol (1992) 0.89
Characterization of insulin receptors in cardiac sarcolemmal and sarcoplasmic reticular membranes. J Cardiovasc Pharmacol (1987) 0.88
Abnormalities in heart membranes and myofibrils during bacterial infective cardiomyopathy in the rabbit. Circ Res (1976) 0.88
Calcium-related changes in the ultrastructure of mammalian myocardium. Br J Exp Pathol (1979) 0.88
Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2+ transport. Arch Biochem Biophys (2001) 0.88
Mechanism for depression of heart sarcolemmal Ca2+ pump by oxygen free radicals. Am J Physiol (1989) 0.88
Involvement of membrane systems in heart failure due to intracellular calcium overload and deficiency. J Mol Cell Cardiol (1976) 0.88
Anti-atherosclerotic molecules targeting oxidative stress and inflammation. Curr Pharm Des (2009) 0.88
Role of H2O2 in changing beta-adrenoceptor and adenylyl cyclase in ischemia-reperfused hearts. Mol Cell Biochem (1998) 0.87
Formation of gigantic mitochondria in hypoxic isolated perfused rat hearts. Experientia (1969) 0.87
Redistribution and abnormal activity of phospholipase A(2) isoenzymes in postinfarct congestive heart failure. Am J Physiol Cell Physiol (2001) 0.87
Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol (1985) 0.86
Protective effect of zinc against catecholamine-induced myocardial changes electrocardiographic and ultrastructural studies. Lab Invest (1981) 0.86
Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res (1990) 0.86
Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem (1995) 0.86
Influence of reducing agents on adrenochrome-induced changes in the heart. Arch Pathol Lab Med (1981) 0.86
Isolation of skeletal muscle membrane fragments containing active Na+-K+ stimulated ATPase: comparison of normal and dystrophic muscle sarcolemma. Biochem Biophys Res Commun (1971) 0.86
Palmitoyl carnitine increases intracellular calcium in adult rat cardiomyocytes. J Mol Cell Cardiol (1999) 0.86
Neuropeptide Y modulation of sympathetic activity in myocardial infarction. J Am Coll Cardiol (1996) 0.85
Responses of contractile function to ruthenium red in rat heart. Am J Physiol (1988) 0.85
Influence of fluothane on calcium accumulation by the heavy microsomal fraction of human skeletal muscle: comparison with a patient with malignant hyperpyrexia. Biochem Med (1972) 0.85
Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol (1988) 0.85
Cardiac membrane Ca(2+)-transport in alloxan-induced diabetes in rats. Diabetes Res Clin Pract (1996) 0.85
Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart. J Pharmacol Exp Ther (2000) 0.85
Free oxygen radicals contribute to high incidence of reperfusion-induced arrhythmias in isolated rat heart. Life Sci (1999) 0.85
Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir. FASEB J (1996) 0.85
Alterations in cardiac contractile proteins due to oxygen free radicals. Biochim Biophys Acta (1991) 0.85
Stunned myocardium and oxygen free radicals--sarcolemmal membrane damage due to oxygen free radicals. Jpn Circ J (1991) 0.84
Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups. Biochim Biophys Acta (1990) 0.84
Ischemic preconditioning prevents I/R-induced alterations in SR calcium-calmodulin protein kinase II. Am J Physiol Heart Circ Physiol (2000) 0.84
Role of Na+-Ca2+ exchange in the development of cardiac abnormalities due to calcium paradox. Eur Heart J (1983) 0.84
Biochemical basis of heart function. X. Reduction in the Na+-K+-stimulated ATPase activity in failing rat heart due to hypoxia. Can J Physiol Pharmacol (1973) 0.84
Energy state and ultrastructure of the substrate-depleted heart. Recent Adv Stud Cardiac Struct Metab (1972) 0.84
Phospholipase A2-mediated activation of phospholipase D in rat heart sarcolemma. J Mol Cell Cardiol (1998) 0.84
Phosphatidic acid increases intracellular free Ca2+ and cardiac contractile force. Am J Physiol (1996) 0.84
Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats. Mol Cell Biochem (1998) 0.84
Calcium pump activity of sarcoplasmic reticulum in diabetic rat skeletal muscle. Am J Physiol (1986) 0.84